 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- || amoxicillin/clavulanic acid (LP-001) / Kaizen Biosci
Enrollment open, Trial completion date, Trial primary completion date: A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection (clinicaltrials.gov) - Feb 7, 2024
P1, N=24, Recruiting, Sponsor: Kaizen Bioscience Co.
Not yet recruiting --> Recruiting | Trial completion date: Mar 2023 --> Jun 2024 | Trial primary completion date: Mar 2023 --> Jun 2024
- | amoxicillin/clavulanic acid (LP-001) / Kaizen Biosci
New P1 trial: A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection (clinicaltrials.gov) - Oct 18, 2022
P1, N=24, Not yet recruiting, Sponsor: Kaizen Bioscience Co.